Market Tracker

07/27 6:01pm ET

Ocata Therapeutics Inc (NASDAQ:OCAT)

During the Trading Day
4.63 -0.065 / -1.39%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.62 -0.0006 / -0.01%
 
Volume: 489.00
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close4.69
Today’s open4.62
Day’s range3.55 - 4.68
Volume487,167
Average volume (3 months)390,802
Market cap$196.8M
Dividend yield--
Data as of 3:59pm ET, 07/27/2015

Growth & Valuation

Earnings growth (last year)-17.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-29.83%
P/E ratioNM
Price/Sales1,206.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...-0.34-7.69%
CYNACynapsus Therapeutic...-0.13-0.78%
NEOTNeothetics Inc-0.08-0.57%
ALIMAlimera Sciences Inc+0.02+0.44%
Data as of 3:59pm ET, 07/27/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$157.9K
Annual profit (last year)-$34.7M
Net profit margin-22,010.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts